A number of antitumor and other bioactive compounds were previously isolated from Vernonia amygdalina Del. This study was designed to further isolate and characterize compounds of medicinal value that may also have antitumor activity from this edible and commonly available plant. Bioassay-guided fractionation of the leaf extract of V. amygdalina (MEVA) led to the isolation and characterization of a known compound, epivernodalol for the first time in this plant. Its structure was identified by spectroscopic methods including 1 H-NMR, 13 C-NMR, MS, UV and IR spectra. In vitro growth inhibitory and cytotoxic evaluation of MEVA, its fractions and epivernodalol against HT-144 (skin melanoma) cell line was carried out by the Sulforhodamine B (SRB) assay. The results showed that epivernodalol and the dichloromethane fraction of V. amygdalina were active against HT-144 (skin melanoma) cell line. Vernonia amygdalina Del. leaf extract yielded another cytotoxic which was active against skin cancer.
Aims:
The aim of the current study was to identify active compound(s) responsible
for the antiproliferative effects of O. basilicum and explore their underlying mechanism/s.
Background: Plants have been the source of medicines for the treatment of various diseases
since ancient times. Ocimum basilicum (Sweet Basil, Bobai Tulsi) has been used in the folk
medicine for the treatment of human liver, spleen and stomach cancers.
Background:
Plants have been the source of medicines for the treatment of various diseases
since ancient times. Ocimum basilicum (Sweet Basil, Bobai Tulsi) has been used in the folk
medicine for the treatment of human liver, spleen and stomach cancers.
Objective:
To emphasize the importance of O. basilicum as a potential novel non-toxic alternative
to the conventional anticancer therapy.
Method:
O. basilicum (aerial parts) methanolic extract and fractions were screened against
HT-144, MCF-7, NCI-H460 and SF-268 human cancer cell lines using sulforhodamine B
assay. The more active Petroleum Ether Insoluble (PEI) fraction was fractionated into six
sub-fractions (OB-1 to OB-6). Four pure compounds (3-O-methyl ursolic acid, oleanolic acid,
3-epi-ursolic acid and ursolic acid) were isolated from the more potent sub-fraction OB-
6. Triple channel immunofluorescence microscopy was employed to observe the effects of
methanolic extract, PEI fraction, sub-fractions OB-5 and OB-6, 3-epi-ursolic acid and
oleanolic acid on the cytoskeleton and nuclei of MCF-7 cells.
Result:
The methanolic extract and the PEI fraction exhibited selectively greater growth inhibition
against MCF-7 cell line (TGI: 56 and 36.2 µg/ml, respectively). By using triple
channel immunofluorescence microscopy, it was observed that the methanolic extract, PEI
fraction, sub-fraction OB-5 and 3-epi-ursolic acid induced irregular mitotic spindle formation
and slowing of mitotic progression in MCF-7 cells while sub-fraction OB-6 induced
mitotic arrest in the prophase stage. F-actin aggregation was also visible in PEI fraction, subfraction
OB-5 and 3-epi-ursolic acid treated MCF-7 cells.
Conclusion:
These results emphasize the importance of O. basilicum as a potential novel
non-toxic alternative to the conventional anticancer therapy and suggest that it inhibits the
growth of MCF-7 cancer cells via multiple mechanisms such as interaction with the microtubules
and mitotic spindle apparatus, and F-actin aggregation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.